P-gp and BCRP are involved in neuroinflammatory responses within the CNS [10] and can be modified by infection and inflammation in different biological barriers, including the BBB [4, 11–13], as well as the intestine [14], the placenta [15–20] and the yolk sac [21–23]. The gene discussed is ABCG2; the disease is infection.